Mass cytometry and single-cell RNA sequencing reveal immune cell characteristics of active and inactive phases of Crohn's disease

质谱流式细胞术和单细胞RNA测序揭示了克罗恩病活动期和非活动期免疫细胞的特征

阅读:2

Abstract

OBJECTIVES: For Crohn's disease (CD), the alternation of the active phase and inactive phase may be related to humoral immunity and cellular immunity. This study aims to understand the characteristics of immune cells in patients with active CD (CDa) and inactive CD (CDin). METHODS: Mass cytometry (CyTOF) and single-cell RNA sequencing (scRNA-seq) data about CDa, CDin, and healthy control (HC) were included. CyTOF analysis was performed to capture gated subsets, including T cells, T regulatory (Treg) cells, B cells, innate immune cells, and natural killer (NK) cells. Differential analysis was used to identify different immune cell subsets among CDa, CDin, and HC. ScRNA-seq analysis was used to verify the results of CyTOF. CD-related signaling pathways were obtained using KEGG pathway enrichment analysis. CellChat analysis was used to infer the cell communication network among immune cell subsets. RESULTS: Compared to patients with CDin, patients with CDa had higher abundances of CD16(+)CD38(+)CD4(+)CXCR3(+)CCR6(+) naive T cells, HLA-DR(+)CD38(+)IFNγ(+)TNF(+) effector memory (EM) T cells, HLA-DR(+)IFNγ(+) naive B cells, and CD14(++)CD11C(+)IFNγ(+)IL1B(+) monocytes. KEGG analysis showed the similarity of pathway enrichment for the earlier four subsets, such as thermogenesis, oxidative phosphorylation, and metabolic pathways. The patients with CDin were characterized by an increased number of CD16(+)CD56(dim)CD44(+)HLA-DR(+)IL22(+) NK cells. Compared to HC, patients with CDa demonstrated a low abundance of HLA-DR(+)CCR6(+) NK cells and a high abundance of FOXP3(+)CD44(+) EM Tregs. CellChat analysis revealed the interaction network of cell subsets amplifying in CDa compared with CDin. CONCLUSION: Some immune subsets cells were identified for CDa and CDin. These cells may be related to the occurrence and development of CD and may provide assistance in disease diagnosis and treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。